Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening in Alzheimer's disease patients
Non-Invasive Blood-Brain Barrier Opening in Alzheimer's Disease Patients Using a Focused Ultrasound Device
Sponsor: National Institute on Aging NIA
Enrolling: Male and Female Patients
Study Length: 4 Months
Clinic Visits: 5
IRB Number: AAAS5163
U.S. Govt. ID: NCT04118764
Contact: Elisa E. Konofagou: 212-342-0863 /
Additional Study Information: A clinical trial that uses focused ultrasound to non-invasively open the blood-brain barrier in Alzheimer's disease patients, in order to help get medication into their brain. In this study, we will focus on the safety and efficacy of this technique, without the use of an anti-Alzheimer's drug. We will also test whether treatment with focused ultrasound alone alters the amyloid protein levels in the treated brain areas and its potential effects on the cognitive function of Alzheimer's patients.
This study is closed
Elisa Konofagou, PhD
Do You Qualify?
Are you 50 years of age or older? Yes No
Are you diagnosed with Alzheimer's Disease? Yes No
Are you able to provide informed consent? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Elisa E. Konofagou